Effects of Proxelan Somministration in Patients With Chronic Prostatitis
NCT ID: NCT03629769
Last Updated: 2018-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
30 participants
INTERVENTIONAL
2017-02-16
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bovine Colostrum Efficacy for the Treatment of Chronic Prostatitis Symptoms.
NCT06804083
Efficacy of Phycocyanin and Palmitoylethanolamide for the Treatment of Chronic Prostatitis Symptoms
NCT07013890
Risk Factors for Chronic Prostatitis Patients in Northwest China
NCT06385977
An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis
NCT00826514
The Role of Butirprost® in Combination With Antibiotics in Chronic Bacterial Prostatitis (CBP) Treatment
NCT06684626
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with prostatitis-like symptoms
Cohort of patients with CP/CPPS (abacterial prostatitis)
Proxelan
Administration of one suppository of proxelan once a day for 30 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Proxelan
Administration of one suppository of proxelan once a day for 30 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Meares and Stamey test suggestive for bacterial infection
* neoplasms,
* urinary stones,
* antibiotic therapy in the previous three months,
* irritable bowel syndrome,
* previous radiotherapic or chemiotherapic treatment,
* urethral stenosis,
* neurogenic bladder
* previous prostatic surgery
18 Years
50 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pisa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Riccardo Bartoletti
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AOUP Ospedale cisanello
Pisa, Tuscany, Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Galeone G, Spadavecchia R, Balducci MT, Pagliarulo V. [The role of Proxelan in the treatment of chronic prostatitis. Results of a randomized trial]. Minerva Urol Nefrol. 2012 Jun;64(2):135-41. Italian.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1103 / 2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.